FDA approves Alvotech-Teva’s SIMLANDI jab for multiple conditions

The US FDA has granted approval for Alvotech and Teva Pharmaceuticals’ SIMLANDI injection, which is an interchangeable biosimilar to Humira.

Feb 26, 2024 - 18:00
FDA approves Alvotech-Teva’s SIMLANDI jab for multiple conditions
The US FDA has granted approval for Alvotech and Teva Pharmaceuticals’ SIMLANDI injection, which is an interchangeable biosimilar to Humira.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow